Minakem Generic APIs Minakem Generic APIs

X

CAS 115555-77-6 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 115555-77-6
Also known as: 115555-77-6, Dibutylaminopropyl chloride, 1-dibutylamino-3-chloropropane hydrochloride, Dibutyl(3-chloropropyl)amine hydrochloride, N-butyl-n-(3-chloropropyl)butan-1-amine;hydrochloride, N-butyl-n-(3-chloropropyl)butan-1-amine (hydrochloride)
Molecular Formula
C11H25Cl2N
Molecular Weight
242.23  g/mol
InChI Key
UURRECHSOADBEG-UHFFFAOYSA-N

1 2D Structure

CAS 115555-77-6

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-butyl-N-(3-chloropropyl)butan-1-amine;hydrochloride
2.1.2 InChI
InChI=1S/C11H24ClN.ClH/c1-3-5-9-13(10-6-4-2)11-7-8-12;/h3-11H2,1-2H3;1H
2.1.3 InChI Key
UURRECHSOADBEG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCN(CCCC)CCCCl.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 115555-77-6

2. Dibutylaminopropyl Chloride

3. 1-dibutylamino-3-chloropropane Hydrochloride

4. Dibutyl(3-chloropropyl)amine Hydrochloride

5. N-butyl-n-(3-chloropropyl)butan-1-amine;hydrochloride

6. N-butyl-n-(3-chloropropyl)butan-1-amine (hydrochloride)

7. 3-(dibutylamino)propyl Chloride Hydrochloride (dbpc.hcl)

8. Dibutylaminopropylchloride

9. Ec 601-371-7

10. Schembl6139434

11. Dtxsid30626717

12. 1-dibutylamino-3-chloropropane Hcl

13. Amy40879

14. Dibutylamino Propylchloride Hcl Salt

15. Akos015901818

16. Dibutylaminopropyl Chloride Hydrochloride

17. Db-060738

18. Ft-0696061

19. En300-65351

20. N-butyl-n-(3-chloropropyl)-1-butanamine Hcl

21. 259d383

22. A893854

23. N-(3-chloropropyl)-n,n-dibutylamine Hydrochloride

24. 1-chloro-3-(di-n-butylamino)-propane Hydrochloride

25. N-butyl-n-(3-chloropropyl)-1-butanamine Hydrochloride

26. N-butyl-n-(3-chloropropyl)butan-1-amine--hydrogen Chloride (1/1)

2.3 Create Date
2007-12-05
3 Chemical and Physical Properties
Molecular Weight 242.23 g/mol
Molecular Formula C11H25Cl2N
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count9
Exact Mass241.1364052 g/mol
Monoisotopic Mass241.1364052 g/mol
Topological Polar Surface Area3.2 Ų
Heavy Atom Count14
Formal Charge0
Complexity88.1
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Flag India
Digital Content Digital Content
URL Supplier Web Content
133238-87-6
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
141645-23-0
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
97-51-8
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
141645-16-1
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY